13F HOLDINGS REPORT
Vantage Consulting Group Inc
Quarter ended Q4 2024 · Filed February 12, 2025 · Accession 0001843547-25-000004
Total Value
$10.5M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Babcock & Wilcox Enterprises Inc. | BW-PA | 2,416,200 | $4.0M | 37.77% |
| 2 | Cibus, Inc. | CBUS | 1,143,949 | $3.2M | 30.31% |
| 3 | ADC Therapeutics SA | ADCT | 850,737 | $1.7M | 16.14% |
| 4 | Potbelly Corporation | 73754Y100 | 164,875 | $1.6M | 14.80% |
| 5 | Fibrogen, Inc | 31572Q808 | 195,707 | $103,627 | 0.99% |